These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1032 related articles for article (PubMed ID: 27720486)
1. A Designer AAV Variant Permits Efficient Retrograde Access to Projection Neurons. Tervo DG; Hwang BY; Viswanathan S; Gaj T; Lavzin M; Ritola KD; Lindo S; Michael S; Kuleshova E; Ojala D; Huang CC; Gerfen CR; Schiller J; Dudman JT; Hantman AW; Looger LL; Schaffer DV; Karpova AY Neuron; 2016 Oct; 92(2):372-382. PubMed ID: 27720486 [TBL] [Abstract][Full Text] [Related]
2. Functional analysis of mutations endowing rAAV2-retro with retrograde tracing capacity. Zhang Y; Wang J; Li J; Chen Y; Sun J; Lu Z; Li Y; Liu T Neurosci Lett; 2022 Jul; 784():136746. PubMed ID: 35718237 [TBL] [Abstract][Full Text] [Related]
3. AAV11 enables efficient retrograde targeting of projection neurons and enhances astrocyte-directed transduction. Han Z; Luo N; Ma W; Liu X; Cai Y; Kou J; Wang J; Li L; Peng S; Xu Z; Zhang W; Qiu Y; Wu Y; Ye C; Lin K; Xu F Nat Commun; 2023 Jun; 14(1):3792. PubMed ID: 37365155 [TBL] [Abstract][Full Text] [Related]
4. A Novel Retrograde AAV Variant for Functional Manipulation of Cortical Projection Neurons in Mice and Monkeys. Chen Y; Wang J; Liu J; Lin J; Lin Y; Nie J; Yue Q; Deng C; Qi X; Li Y; Dai J; Lu Z Neurosci Bull; 2024 Jan; 40(1):90-102. PubMed ID: 37432585 [TBL] [Abstract][Full Text] [Related]
9. A combination of mutations enhances the neurotropism of AAV-2. Xu J; Ma C; Bass C; Terwilliger EF Virology; 2005 Oct; 341(2):203-14. PubMed ID: 16102794 [TBL] [Abstract][Full Text] [Related]
10. Rational design and engineering of a modified adeno-associated virus (AAV1)-based vector system for enhanced retrograde gene delivery. Davis AS; Federici T; Ray WC; Boulis NM; OʼConnor D; Clark KR; Bartlett JS Neurosurgery; 2015 Feb; 76(2):216-25; discussion 225. PubMed ID: 25549186 [TBL] [Abstract][Full Text] [Related]
11. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Burger C; Gorbatyuk OS; Velardo MJ; Peden CS; Williams P; Zolotukhin S; Reier PJ; Mandel RJ; Muzyczka N Mol Ther; 2004 Aug; 10(2):302-17. PubMed ID: 15294177 [TBL] [Abstract][Full Text] [Related]
12. Utilizing minimally purified secreted rAAV for rapid and cost-effective manipulation of gene expression in the CNS. Goodwin MS; Croft CL; Futch HS; Ryu D; Ceballos-Diaz C; Liu X; Paterno G; Mejia C; Deng D; Menezes K; Londono L; Arjona K; Parianos M; Truong V; Rostonics E; Hernandez A; Boye SL; Boye SE; Levites Y; Cruz PE; Golde TE Mol Neurodegener; 2020 Mar; 15(1):15. PubMed ID: 32122372 [TBL] [Abstract][Full Text] [Related]
13. Differences in neurotropism and neurotoxicity among retrograde viral tracers. Sun L; Tang Y; Yan K; Yu J; Zou Y; Xu W; Xiao K; Zhang Z; Li W; Wu B; Hu Z; Chen K; Fu ZF; Dai J; Cao G Mol Neurodegener; 2019 Feb; 14(1):8. PubMed ID: 30736827 [TBL] [Abstract][Full Text] [Related]
14. Intravenous administration of the adeno-associated virus-PHP.B capsid fails to upregulate transduction efficiency in the marmoset brain. Matsuzaki Y; Konno A; Mochizuki R; Shinohara Y; Nitta K; Okada Y; Hirai H Neurosci Lett; 2018 Feb; 665():182-188. PubMed ID: 29175632 [TBL] [Abstract][Full Text] [Related]
15. Intraspinal and Intracortical Delivery of AAV Vectors for Intersectional Circuit Tracing in Non-transgenic Species. Conner JM; Bain GL; Dulin JN Methods Mol Biol; 2019; 1950():165-176. PubMed ID: 30783973 [TBL] [Abstract][Full Text] [Related]
16. Generation of efficient human blood progenitor-targeted recombinant adeno-associated viral vectors (AAV) by applying an AAV random peptide library on primary human hematopoietic progenitor cells. Sellner L; Stiefelhagen M; Kleinschmidt JA; Laufs S; Wenz F; Fruehauf S; Zeller WJ; Veldwijk MR Exp Hematol; 2008 Aug; 36(8):957-64. PubMed ID: 18495326 [TBL] [Abstract][Full Text] [Related]
17. Context-Specific Function of the Engineered Peptide Domain of PHP.B. Martino RA; Fluck EC; Murphy J; Wang Q; Hoff H; Pumroy RA; Lee CY; Sims JJ; Roy S; Moiseenkova-Bell VY; Wilson JM J Virol; 2021 Sep; 95(20):e0116421. PubMed ID: 34346767 [TBL] [Abstract][Full Text] [Related]
18. Cellular selectivity of AAV serotypes for gene delivery in neurons and astrocytes by neonatal intracerebroventricular injection. Hammond SL; Leek AN; Richman EH; Tjalkens RB PLoS One; 2017; 12(12):e0188830. PubMed ID: 29244806 [TBL] [Abstract][Full Text] [Related]
19. Directed evolution of adeno-associated virus for efficient gene delivery to microglia. Lin R; Zhou Y; Yan T; Wang R; Li H; Wu Z; Zhang X; Zhou X; Zhao F; Zhang L; Li Y; Luo M Nat Methods; 2022 Aug; 19(8):976-985. PubMed ID: 35879607 [TBL] [Abstract][Full Text] [Related]
20. Recombinant adeno-associated virus serotype 6 (rAAV2/6)-mediated gene transfer to nociceptive neurons through different routes of delivery. Towne C; Pertin M; Beggah AT; Aebischer P; Decosterd I Mol Pain; 2009 Sep; 5():52. PubMed ID: 19737386 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]